<DOC>
	<DOCNO>NCT02238821</DOCNO>
	<brief_summary>The MET oncogene know sustain Trousseau 's syndrome murine experimental model , feature association carcinogenesis blood procoagulant disorder . MET frequently overexpressed colorectal cancer , tumor venous thromboembolism ( VTE ) may occur association poor prognosis , biological genetic factor cause VTE still obscure . The Investigators propose study whether patient harbor surgically resectable colorectal cancer MET oncogene express may associate blood thrombophilic condition favor onset VTE . These data would two main implication : ( ) first time , direct genetic link MET oncogene procoagulant disorder would demonstrate human ; ( ii ) procoagulant alteration would diagnostic/prognostic significance identification patient risk poor outcome , implementation appropriate therapeutic protocol .</brief_summary>
	<brief_title>Role MET Oncogene Human Colorectal Cancer - A Translational Study</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>age &gt; = 18 ; age &lt; = 80 ; Clinical diagnosis colorectal tumor CT , MRI endoscopy ; surgically resectable tumor ; Inclusion clinical protocol require administration anticoagulant drug ; Life expectancy &lt; 6 month ; Clinical diagnosis thrombophilic condition laboratory analysis ; Previously implant Central Venous Catheter ; Previous concomitant second neoplasia ; Clinical diagnosis kidney , liver heart failure ; Inflammatory marker alteration associate disease unrelated neoplasia ( infection , connective tissue disease etc ) ; Severe hemostasis disorder ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>resectable colorectal cancer</keyword>
</DOC>